1.杨琳琳. 菝葜多糖改善对乙酰氨基酚诱导小鼠急性肝损伤的作用及机制研究[D]. 武汉: 华中科技大学, 2021. DOI: 10.27157/d.cnki.ghzku.2021.005485.
2.曾晓霞, 陈锡林. 菝葜传统应用和现代研究概况[J]. 中草药, 2008, 39(6): 952-954. DOI: 10.3321/j.issn: 0253-2670.2008.06.049.
3.中国药典2020年版. 四部[S]. 2020: 321-322.
4.王福燕, 江丰, 范小龙, 等. 基于化学成分药理作用及网络药理学的菝葜质量标志物预测分析[J]. 时珍国医国药, 2022, 33(11): 2805-2809. [Wang FY, Jiang F, Fan XL, et. Prediction and analysis of quality markers of Smilax china based on pharmacological action of chemical constituents and network pharmacology[J]. Lishizhen Medicine and Materia Medica Research, 2022, 33(11): 2805-2809.] DOI: 10.3969/j.issn.1008-0805.2022.11.74.
5.Ru JL, Li P, Wang JN, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014, 6(1): 13. DOI: 10.1186/1758-2946-6-13.
6.Xu HY, Zhang YQ, Liu ZM, et al. ETCM: an encyclopaedia of traditional Chinese medicine[J]. Nucleic Acids Res, 2019, 47(D1): D976-D982. DOI: 10.1093/nar/gky987.
7.Shao B, Guo HZ, Cui YJ, et al. Steroidal saponins from Smilax china and their anti-inflammatory activities[J]. Phytochemistry, 2007, 68(5): 623-630. DOI: 10.1016/j.phytochem.2006.10.026.
8.徐燕, 王海燕, 蒋家月, 等. 菝葜中的甾体皂苷及其细胞毒活性[J]. 中国实验方剂学杂志, 2011, 17(11): 92-96. [Xu Y, Wang HY, Jiang JY, et al. Studies on steroidal saponins from Smilax china and their cytotoxic activities[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2011, 17(11): 92-96.] DOI: 10.3969/j.issn.1005-9903.2011.11.029.
9.胡灯. 菝葜的甾体皂苷成分及其抗肿瘤活性研究[D]. 广州: 南方医科大学, 2017. DOI: 10.27003/d.cnki.gojyu. 2017.000154.
10.时向利, 朱倩. HPLC法同时测定不同产地菝葜中5种成分的含量[J]. 化工设计通讯, 2022, 48(11): 237-239. [Shi XL, Zhu Q. The contents of five components in different origin were determined simultaneously by HPLC[J]. Chemical Engineering Design Communications, 2022, 48(11): 237-239] DOI: 10.3969/j.issn.1003-6490. 2022.11.079.
11.徐梦. 菝葜多酚成分分析及其生物活性研究[D]. 南昌: 江西农业大学, 2020. DOI: 10.27177/d.cnki.gjxnu.2020.000423.
12.陈佳倩, 金晨, 徐博伦, 等. 菝葜总黄酮主成分鉴定及苯酚胶浆诱导大鼠盆腔炎的抗炎作用评价[J]. 中国药学(英文), 2021, 30(2): 157-168. [Chen JQ, Jin C, Xu BL, et al. Identification of major compounds of total flavonoids from Smilax china and evaluation of anti-inflammatory effect on phenol mucilage-induced pelvic inflammation in rats[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(2): 157-168.] DOI: 10.5246/jcps.2021.02.013.
13.冯锋, 柳文媛, 陈优生, 等. 菝葜中黄酮和芪类成分的研究[J]. 中国药科大学学报, 2003, (2): 23-25. [Feng F, Liu WY, Chen YS, et al. Flavonoids and stilbenes from Smilax china[J]. Journal of China Pharmaceutical University, 2003, (2): 23-25.] DOI: 10.3321/j.issn:1000- 5048.2003.02.005.
14.邵波,郭洪祝,果德安. 菝葜中黄酮和二苯乙烯类成分的研究[J]. 中草药, 2009, 40(11): 1700-1703. [Shao B, Guo HZ, Guo DA. Flavonoids and stilbenes from Smilax china[J]. Chinese Traditional and Herbal Drugs, 2009, 40(11): 1700-1703]. DOI: 10.3321/j.issn:0253-2670. 2009.11.004.
15.Yang CH, Tang QF, Liu JH, et al. Preparative isolation and purification of phenolic acids from Smilax china by high-speed counter-current chromatography[J]. Sep Purif Technol, 2008, 61(3): 474-478. DOI: 10.1016/j.seppur.2008.02.017.
16.Zheng XW, Zhang L, Zhang WY, et al. Two new xanthones, a new lignin, and twenty phenolic compounds from Smilax china and their NO production inhibitory activities[J]. J Asian Nat Prod Res, 2020, 22(6): 509-520. DOI: 10.1080/10286020.2019.1598395.
17.干国平,于伟,刘焱文. 菝葜化学成分的研究[J]. 时珍国医国药, 2007, 18(6): 1404-1405. [Gan GP, Yu W, Liu YW. Studies on chemical constituents of Smilax china L.[J]. Lishizhen Medicine and Materia Medica Research, 2007, 18(6): 1404-1405.] DOI: 10.3969/j.issn.1008-0805.2007.06.067.
18.Li YT, Feng X, Feng YJ, et al. Steroidal saponins from the rhizomes of Smilax china and their inhibitory effects on lipopolysaccharide-induced proinflammatory cytokines expression[J]. Planta Med, 2023, 89(2): 208-217. DOI: 10.1055/a-1896-1098.
19.Li X, Chu LL, Liu SS, et al. Smilax china L. flavonoid alleviates HFHS-induced inflammation by regulating the gut-liver axis in mice[J]. Phytomedicine, 2022, 95: 153728. DOI: 10.1016/j.phymed.2021.153728.
20.Zhang Y, Pan XL, Ran SQ, et al. Purification, structural elucidation and anti-inflammatory activity in vitro of polysaccharides from Smilax china L.[J]. Int J Biol Macromol, 2019, 139: 233-243. DOI: 10.1016/j.ijbiomac. 2019.07.209.
21.Jiang SY, Wei Q, Ye XC, et al. The anti-inflammatory effect of Smilax china L. extract on LPS-stimulated THP-1 via downregulation of MAPK and NF-κB signaling pathway[J]. Evid Based Complement Alternat Med, 2021, 2021: 9958808. DOI: 10.1155/2021/9958808.
22.邓青芳, 周欣, 陈华国. 多糖抗肝损伤作用及其机制研究进展[J]. 中国中药杂志, 2016, 41(16): 2958-2967. [Deng QF, Zhou X, Chen HG. Advance in study on hepatoprotective effects and its mechanism of polysaccharides[J]. China Journal of Chinese Materia Medica, 2016, 41(16): 2958-2967.] DOI: 10.4268/cjcmm 20161603.
23.Wang KP, Yang LL, Zhou J, et al. Smilax china L. Polysaccharide alleviates oxidative stress and protects from acetaminophen-induced hepatotoxicity via activating the Nrf2-ARE pathway[J]. Front Pharmacol 2022, 13: 888560. DOI: 10.3389/fphar.2022.888560.
24.褚路路. 菝葜多糖的理化性质、护肝活性及菝葜淀粉复合凝胶体系的探究[D]. 南昌: 江西农业大学, 2019. DOI: 10.27177/d.cnki.gjxnu.2019.000328.
25.Boby N, Lee EB, Abbas MA, et al. Ethanol-induced hepatotoxicity and alcohol metabolism regulation by GABA-enriched fermented Smilax china root extract in rats[J]. Foods, 2021, 10(10): 2381. DOI: 10.3390/foods 10102381.
26.Ma Y, Pei TT, Song LY, et al. Flavonoids from Smilax china L. Rhizome improve chronic pelvic inflammatory disease by promoting macrophage reprogramming via the NLRP3 inflammasome-autophagy pathway[J]. J Funct Foods, 2023, 109: 105802. DOI: 10.1016/j.jff.2023.105802.
27.Pan XL, Wang HY, Zheng ZM, et al. Pectic polysaccharide from Smilax china L. ameliorated ulcerative colitis by inhibiting the galectin-3/NLRP3 inflammasome pathway[J]. Carbohydr Polym, 2022, 277: 118864. DOI: 10.1016/j.carbpol.2021.118864.
28.Xu M, Xue H, Qiao GX, et al. Regulating the imbalance of gut microbiota by Smilax china L. polyphenols to alleviate dextran sulfate sodium-induced inflammatory bowel diseases[J]. Am J Chin Med, 2022, 50(2): 553-568. DOI: 10.1142/S0192415X22500215.
29.邝玉慧, 徐方飚, 陈晓琦, 等. 基于计算机虚拟筛选研究菝葜抗肝癌的作用机制[J]. 中医学报, 2021, 36(8): 1751-1757. [Kuang YH, Xu FB, Chen XQ, et al. Study of anti-liver cancer mechanism of Baqia (Smilax china L.) based on computer virtual screening[J]. Acta Chinese Medicine, 2021, 36(8): 1751-1757.] DOI: 10.16368/j.issn.1674-8999.2021.08.365.
30.朱立华, 周融融, 黄生武, 等. 基于网络药理学探析复方菝葜治疗非小细胞肺癌的机制[J]. 中医药导报, 2023, 29(8): 132-139. [Zhu LH, Zhou RR, Huang SW, et al. Study on the mechanism of compound Baqia (Smilacis chinae rhizoma) in the treatment of non-small cell lung cancer based on network pharmacology[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2023, 29(8): 132-139.] DOI: 10.13862/j.cn43-1446/r.2023. 08.026.
31.于丽秀, 胡丽玲, 廖婧, 等. 菝葜不同提取部位对卵巢癌细胞的活性影响[J]. 中国药师, 2015, 18(3): 373-375. [Yu LX, Hu LL, Liao J, et al. Effect of different extracts of Smilax china L. on the activity of ovarian cancer cells[J]. China Pharmacist, 2015, 18(3): 373-375.] DOI: 10.3969/j.issn.1008-049X.2015.03.005.
32.Fu S, Yang YF, Liu D, et al. Flavonoids and tannins from Smilax china L. rhizome induce apoptosis via mitochondrial pathway and MDM2-p53 signaling in human lung adenocarcinoma cells[J]. Am J Chin Med, 2017, 45(2): 369-384. DOI: 10.1142/S0192415X17500239.
33.邱千, 邓爱萍, 戴琪, 等. 菝葜鞣质抗肺癌活性研究 [J]. 湖北中医药大学学报, 2017, 19(1): 43-47. [Qiu Q, Deng AP, Dai Q, et al. Study on anti-lung cancer activity of tannins from Smilax china L.[J]. Journal of Hubei University of Chinese Medicine, 2017, 19(1): 43-47.] DOI: 10.3969/j.issn.1008-987x.2017.01.12.
34.Chalertpet K, Sangkheereeput T, Somjit P, et al. Effect of Smilax spp. and Phellinus linteus combination on cytotoxicity and cell proliferation of breast cancer cells[J]. BMC Complement Med Ther, 2023, 23(1): 177. DOI: 10.1186/s12906-023-04003-x.
35.郭红, 黄艳丽, 邢辉, 等. 菝葜皂苷元调控circ-PRKCI/miR-130a-5p抑制卵巢癌细胞CAOV3增殖、迁移及侵袭[J]. 时珍国医国药, 2021, 32(12): 2875-2878. [Guo H, Huang YL, Xing H, et al. circ-PRKCI/miR-130a-5p regulates the proliferation, migration and invasion of CAOV3 ovarian cancer cells[J]. Lishizhen Medicine and Materia Medica Research, 2021, 32(12): 2875-2878.] DOI: 10.3969/j.issn.1008-0805.2021.12.14.
36.吴源陶, 邹译娴, 张春虎, 等. 菝葜皂苷元对结直肠癌细胞HT-29凋亡和自噬的影响[J]. 湖南中医药大学学报, 2021, 41(11): 1645-1649. [Wu YT, Zou YX, Zhang CH, et al. Effect of sarsasapogenin on apoptosis and autophagy of colorectal cancer lines HT-29[J]. Journal of Hunan University of Chinese Medicine, 2021, 41(11): 1645-1649.] DOI: 10.3969/j.issn.1674-070X.2021.11.001.
37.廖子君, 郑琪, 赵征,等. 菝葜皂苷对胃癌BGC-823细胞Bcl-2、Bax凋亡蛋白表达影响的实验研究[J]. 中国医药指南, 2018, 16(18): 1-2. [Liao ZJ, Zheng Q, Zhao Z, et al. Study on the effect of sarsasapogenin to apoptosis of Bax and Bcl-2 protein expression of human gastric cancer lines BGC-823[J]. Guide of China Medicine, 2018, 16(18): 1-2.] DOI: CNKI:SUN:YYXK.0.2018-18-002.
38.Wang C, Zhou Q, Wu ST. Scopolin obtained from Smilax china L. against hepatocellular carcinoma by inhibiting glycolysis: a network pharmacology and experimental study[J]. J Ethnopharmacol, 2022, 296: 115469. DOI: 10.1016/j.jep.2022.115469.
39.Wu ST, Yuan Z, Piao XL, et al. The active components of Smilax china L. against cancer by interfering with the interactions among associated proteins[J]. J Funct Foods, 2023, 106: 105591. DOI: 10.1016/j.jff.2023.105591.
40.Silva ICA, Azevedo LS, Castro AHF, et al. Chemical profile, antioxidant potential and toxicity of Smilax brasiliensis Sprengel (Smilacaceae) stems[J]. Food Res Int, 2023, 168: 112781. DOI: 10.1016/j.foodres.2023.112781.
41.李俊芳, 蓝青, 李兰芳, 等. 粉背菝葜抗氧化作用预实验[J]. 广州化工, 2021, 49(24): 31-33, 36. [Li JF, Lan Q, Li LF, et al. Preliminary experiments on antioxidation of Smilax hypoglauca[J]. Guangzhou Chemical Industry, 2021, 49(24): 31-33, 36.] DOI: 10.3969/j.issn.1001-9677. 2021.24.011.
42.Joo JH, Han MH, Kim JI, et al. Antimicrobial activity of Smilax china L. root extracts against the acne-causing bacterium, Cutibacterium acnes, and its active compounds[J]. Molecules, 2022, 27(23): 8331. DOI: 10.3390/molecules27238331.
43.Xu M, Xue H, Li X, et al. Chemical composition, antibacterial properties, and mechanism of Smilax china L. polyphenols[J]. Appl Microbiol Biotechnol, 2019, 103(21-22): 9013-9022. DOI: 10.1007/s00253-019-10100-0.
44.Li X, Yang LC, Li JG, et al. A flavonoid-rich Smilax china L. extract prevents obesity by upregulating the adiponectin-receptor/AMPK signalling pathway and modulating the gut microbiota in mice[J]. Food Funct, 2021, 12(13): 5862-5875. DOI: 10.1039/d1fo00282a.
45.Zhang Y, Pan XL, Ran SQ, et al. Purification, structural elucidation and anti-inflammatory activity in vitro of polysaccharides from Smilax china L.[J]. Int J Biol Macromol, 2019, 139: 233-243. DOI: 10.1016/j.ijbiomac. 2019.07.209.
46.Kong L, Zhang WK, Liu SS, et al. Quercetin, engelitin and caffeic acid of Smilax china L. polyphenols, stimulate 3T3-L1 adipocytes to brown-like adipocytes via β3-AR/AMPK signaling pathway[J]. Plant Foods Hum Nutr, 2022, 77(4): 529-537. DOI: 10.1007/s11130-022-00996-x.
47.Yang LC, Zhao Y, Pan YF, et al. Dietary supplement of Smilax china L. ethanol extract alleviates the lipid accumulation by activating AMPK pathways in high-fat diet fed mice[J]. Nutr Metab (Lond), 2019, 16: 6. DOI: 10.1186/s12986-019-0333-z.
48.郑国栋, 朱晓娟, 张清峰, 等. 菝葜对小鼠肝脏脂肪代谢的影响[J]. 中国食品学报, 2016, 16(3): 30-35. [Zheng GD, Zhu XJ, Zhang QF, et al. Effects of Smilax china L. on hepatic fat metabolism in mice[J]. Journal of Chinese Institute of Food Science and Technology, 2016, 16(3): 30-35.] DOI: 10.16429/j.1009-7848.2016.03.004.
49.赵磊. 土茯苓总黄酮与肠道菌群相互作用的研究 [D]. 江苏苏州: 苏州大学, 2020. DOI: 10.27351/d.cnki.gszhu. 2020.003959.
50.Chen LY, Yin HF, Lan Z, et al. Anti-hyperuricemic and nephroprotective effects of Smilax china L.[J]. J Ethnopharmacol, 2011, 135(2): 399-405. DOI: 10.1016/j.jep.2011.03.033.
51.Li X, Liu SS, Jin WL, et al. Identification of the constituents of ethyl acetate fraction from Smilax china L. and determination of xanthine oxidase inhibitory properties[J]. Int J Mol Sci, 2023, 24(6): 5158. DOI: 10.3390/ijms24065158.
52.Zhao BT, Le DD, Nguyen PH, et al. PTP1B, α-glucosidase, and DPP-IV inhibitory effects for chromene derivatives from the leaves of Smilax china L.[J] Chem Biol Interact, 2016, 253: 27-37. DOI: 10.1016/j.cbi.2016.04.012.